IDH1 INHIBITORS FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS

摘要

Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.